Thrombosis

MD IQ

News

Canada approves Jivi for hemophilia A

Health Canada has approved Jivi® (antihemophilic factor [recombinant, B-domain deleted, PEGylated]) for use in patients with hemophilia A. Jivi (...

News

CHMP recommends change for eptacog alfa

The European Medicine’s Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended a change to the terms of the marketing...

News

Obese PE patients have lower risk of death

SAN ANTONIO—Patients with pulmonary embolism (PE) have a lower mortality risk if they are obese, according to a retrospective analysis of nearly 2...

Pages